dr. brufsky discusses adjuvant bisphosphonates as a new standard of care
Published 10 years ago • 52 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
11:19
bisphosphonate use in breast cancer
-
2:47
adam brufsky, md, phd: clinical trial data supporting these choices
-
1:16
dr. brufsky advises doctors on bevacizumab for breast cancer
-
1:22
dr. brufsky on cobimetinib plus paclitaxel in tnbc
-
1:12
dr adam brufsky outlines care coordination in oncology
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
2:06
asco update: bisphosphonate effect in breast cancer
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
1:26
dr. burstein on adjuvant endocrine therapy for er breast cancer
-
1:04
dr. brufsky on the disease-free survival of aromatase inhibitors for breast cancer
-
2:32
adam brufsky, md - university of pittsburgh medical center
-
1:25
dr. brufsky addresses biosimilar skepticism
-
1:41
dr. coleman on findings from the azure trial for breast cancer treatment
-
1:43
phase ii pathway: adjuvant pembrolizumab in patients with hnsc cancer at high risk for recurrence
-
1:32
atrial fibrillation after a stroke and the concept of afdas
-
2:00
professor ingunn holen and research into bisphosphonates for breast cancer